ÂÜÀòÂÒÂ×

Colin Sims is currently the CEO of adthera bio, a digital-first, platform agnostic CGT dedicated CDMO. Prior to this, Colin served as the Non-Executive Chairman at Thromboserin Limited and as a Senior Partner at Delin Ventures. Colin has a wealth of experience in the pharmaceutical and healthcare industries, having held executive positions at companies such as Kyowa Kirin International plc and Novartis. Colin has a strong educational background, with degrees from Harvard Business School, King's College London, and the University College Hospital, University of London.